Modern views for the treatment of placental dysfunction in pregnant after IVF




pregnancy, in vitro fertilization, placental dysfunction, treatment


With the introduction of in vitro fertilization, the quantity of problems associated with the high incidence of obstetric and perinatal pathology in women with induced pregnancy have increased. The purpose of the study was to evaluate the effectiveness of complex therapy aimed at the prevention and treatment of placental dysfunction in pregnant women after in vitro fertilization.

Under observation there were 23 pregnant women after in vitro fertilization (main group) and 20 women with physiological pregnancy (control group). Exclusion criteria from the study were multiple pregnancy, abnormal development of the female genital organs, severe extragenital pathology in mother, congenital abnormalities of the fetus.

Considering the decrease in chorion vascularization, its hypoplasia, as well as hemodynamic disturbances in the myometrium at the end of the first trimester of gestation in pregnant women after IVF, it can be said with certainty that in addition to hormonal support in patients with induced pregnancy, therapy is aimed at normalizing uterine-chorial blood flow, restoration of effective embryo-chorial relationships.

To this end, we have proposed a complex of therapeutic agents, which includes venotonic Normoven 1 tablet 2 times a day and Magnicum1 tablet 3 times a day. In order to activate metabolic processes in the body, the drug Arthiol was administered of 600–1200 mg per day before a meal. The treatment was performed twice at 10–12 and 15–18 weeks of gestation.

The proposed complex of therapeutic agents helps to normalize uterine-chorial blood flow, restore effective embryo-chorial relationships, and significantly reduces the incidence of placental dysfunction in the future.

Author Biography

О. В. Кравченко, Bukovinian State Medical University, Chernivtsi

MD, professor, head of Obstetrics, Gynecology and Perinatology Department


  1. Anchakova, M.H. Features of the course of pregnancy, delivery and the postpartum period in women after IVF and ET. Thesis abstract for PhD degree, specialty 14.00.01 “Obstetrics and Gynecology”. Moscow (2007): 20 p.
  2. Buranova, F.B. “Actual aspects of the etiology, pathogenesis, diagnosis and treatment of placental insufficiency in pregnant women after in vitro fertilization.” Obstetrics and Gynecology 6 (2011): 9–16.
  3. Velieva, E.E., Smolnikova, V.Y., Kuzmichev, L.N. “The role of immunogenetic examination in the in vitro fertilization program.” Russian Medical Journal 6 (2009): 47–9.
  4. Dolgieva, L.U. Optimization of delivery of pregnant women after in vitro fertilization. Thesis abstract for PhD degree, specialty 14.00.01 “Obstetrics and Gynecology”. Moscow (2010): 22 p.
  5. Kalinina, E.A. Reserves of increase of efficiency of in vitro fertilization in the treatment of infertility in women with gynecological diseases. Thesis abstract for MD degree, specialty 14.00.01 “Obstetrics and Gynecology”. Moscow (2005): 20 p.
  6. Krasnopolskaya, K.V. “New approaches to the restoration of natural fertility in polycystic ovary syndrome and their impact on the therapeutic potential of in vitro fertilization.” Obstetrics and Gynecology 2 (2008): 50–5.
  7. Mikheeva, E.M., Penkina, N.I. “The course and outcome of pregnancy in women with a history of infertility.” Treatment and prevention 2.10 (2014): 15–9.
  8. Radzinskyi, V.E., Orazmuradova, A.A. Early periods of pregnancy. 2nd ed. Moscow. Status Praesens (2009): 478 p.
  9. Savelieva, G.M., Kurtser, M.A., Krasnopolskaya, K.V., Eroyan, L.H. “IVF in the treatment of infertility. Management of pregnancy and childbirth.” Journal of Obstetrics and Women’s Diseases 3.3 (2003): 9–13.
  10. Sidorova, I.S., Makarov. I.O. Clinical and diagnostic aspects of placental insufficiency. Moscow. MIA (2005): 296 p.
  11. Tumanova L.E., Molchanova, O.O., Kolomiets, O.V. “The course of pregnancy, childbirth and state of newborns in women after IVF by the method of ICSI.” Perinatology and Pediatrics 4.60 (2014): 34–9.
  12. Hasheesha, M.H. “Hormonal and hemostasiological parameters in women with complicated pregnancy in the first trimester after in vitro fertilization.” Obstetrics and Gynecology 4 (2007): 26–30.
  13. Baschat, A.A., Hecher, K. “Fetal growth restriction due to placental disease.” Semin Perinatol 28.1 (2004): 67–80.
  14. Delbaere, I., Vansteelandt, S., Gerris, J., et al. “Human chorionic gonadotropin levels in early IVF/ICSI pregnancies are higher in singletons after single embryo transfer compared with singletons after double embryo transfer.” Hum Reprod 23.11 (2008): 2421–6.
  15. Griesinger, G., Kolibianakis, E.M., Diedrich, K., et al. “Ovarian stimulation for IVF has no quantitative association with birthweight: a registry study.” Hum Reprod 23.11 (2008): 2549–54.
  16. Isaksson, R., Gissler, M., Tiitinen, A. “Obstetricoutcome among women with unexplained infertility aft er IVF: a matched case-control study.” Hum Reprod 17.7 (2002): 1755–61.
  17. Poikkeus, P., Gissler, M., Unkila-Kallio, L., et al. “Obstetric and neonatal outcome after single embryo transfer.” Hum Reprod 22.4 (2007): 1073–9.
  18. Verhagen, T.E.M., Dumoulin, J.C.M., Evers, J.L.H., Land, J.A. “What is the most accurate estimate of pregnancy rates in IVF dropouts?” Hum Reprod 23.8 (2008): 1793–9.



How to Cite

Кравченко, О. В. (2018). Modern views for the treatment of placental dysfunction in pregnant after IVF. REPRODUCTIVE ENDOCRINOLOGY, (44), 30–34.



Pregnancy and childbirth

Most read articles by the same author(s)

1 2 > >>